Yoga Nidra for Health & Longevity - Quick Reference Sheet

Yoga Nidra for Health & Longevity

Created on 09/03/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5 – Audit

A free, guided lying-down practice of ten to thirty minutes, needing no equipment or physical capacity. The firmest findings are lower blood pressure and lower self-reported anxiety and stress, with sleep close behind. It easily beats doing nothing but often fails to beat another structured relaxation technique. Harms are mild, greatest where unresolved trauma is present. (Full Review)

Protocol

Session length
10–40 minutes
Trials used 10–11, 16, 25, 30 and 35–40 minutes. The 11-minute and 30-minute forms were compared head to head; both worked, with the longer form better on awareness measures.
Frequency
Daily to five sessions weekly
Cardiac and hormonal trials used daily practice for three to six months; mental-health effects appeared within two to four weeks.
Posture
Supine in savasana
Lying flat on the back, legs apart and palms up, optionally with a flat support under the lower back. Seated is the standard substitute where sleep intrusion or reflux is a problem.
Time to effect
Anxiety and perceived stress
2–4 weeks
Anxiety scores shifted within two to four weeks of near-daily practice.
Resting blood pressure
First session; 1–3 months
Blood pressure fell acutely from the first session but needed one to three months for a sustained change.
Subjective sleep quality
2–4 weeks
Sleep scores shifted within two to four weeks of near-daily practice.

Benefits

Contraindications
  • Active psychosis or a current manic episode
  • Post-traumatic stress disorder with current dissociative symptoms (unless a trauma-informed protocol is used with clinical supervision)
  • Symptomatic orthostatic hypotension (documented drop above 20 mm Hg systolic), until the transition out of lying flat is managed
  • Untreated moderate-to-severe obstructive sleep apnoea
Key Interactions
  • Antihypertensives (amlodipine, lisinopril, losartan, hydrochlorothiazide)
  • Sedative-hypnotics and benzodiazepines (zolpidem, temazepam, lorazepam)
  • Insulin and sulfonylureas (glipizide, glimepiride)
  • Alcohol and cannabis (over-the-counter and recreational)
  • Over-the-counter sedating antihistamines (diphenhydramine, doxylamine)
  • Sedating and blood-pressure-lowering supplements (melatonin, valerian, magnesium glycinate, ashwagandha)
  • Blood-pressure-lowering supplements with additive effects (beetroot or dietary nitrate, hibiscus, potassium, magnesium)
  • Other behavioural interventions (cognitive behavioural therapy for insomnia, mindfulness-based stress reduction, breathwork, sauna)

Risk & Side Effects

  • High:
  • Medium: Unpleasant or distressing meditation-related experiences
  • Low: Trauma re-experiencing in people with post-traumatic stress; falling fully asleep and post-practice drowsiness; no added benefit over an active alternative
  • Speculative: Symptomatic low blood pressure alongside antihypertensive medication; displacement of night-time sleep pressure

Monitoring

Marker Target Why
Home blood pressure 110–120 / 70–75 mm Hg The best-supported measurable target of the practice
Resting heart rate 50–65 beats per minute Tracks the shift toward the rest-and-digest side of the nervous system
Heart rate variability No established target; rising seven-day rolling average against the individual's own 30-day baseline Direct index of vagal nerve activity, the mechanism behind the blood pressure effect
Pittsburgh Sleep Quality Index 5 or below Validated sleep-quality questionnaire used in most trials
Insomnia Severity Index 7 or below The scale on which the clearest randomised sleep benefit was measured
Morning salivary cortisol 0.3–0.7 µg/dL at 30 minutes after waking Captures the stress-hormone output the practice reduces
High-sensitivity C-reactive protein Below 1.0 mg/L General inflammatory load, a slow-moving background marker
Glycated haemoglobin 4.8–5.3% Average blood sugar, relevant given the glucose finding
Fasting glucose 75–86 mg/dL Detects the glucose shift seen in the diabetes trial
Thyroid-stimulating hormone 0.5–2.0 mIU/L Only relevant where menstrual irregularity is the reason for practising

Cadence: Home blood pressure weekly for the first eight weeks, then monthly. Sleep and anxiety questionnaires at four weeks, twelve weeks, then every six months. Blood tests at three months, then every six to twelve months.

Qualitative Assessment

  • Whether sessions end in alert rest or in sleep, recorded as a simple daily tally
  • Time from lights out to sleep on nights following an evening session
  • Afternoon energy and mental clarity in the two hours after a daytime session
  • Reactivity to a known daily stressor, rated on a simple 0–10 scale each evening
  • Whether any distress raised during a session resolves before the session ends